FiercePharma‘s list of highest-paid biopharma CEOs includes both midsized companies and some of the industry’s largest drugmakers. U.S. companies dominated the list, and CEOs at midsize […]
Proteus Digital Health, makers of an ingestible sensor embedded within a pill to track medication usage, has filed for bankruptcy after failing to raise funding. […]
Takeda is set to spend nearly $1B in backloaded payments for a deal with startup Carmine Therapeutics. They will target rare diseases using gene therapies out […]
After the deaths of George Floyd, Ahmaud Arbery, and Breonna Taylor, Americans have spoken up about racial inequalities, police violence, and systemic racism. Biopharma leaders are […]
According to consensus forecasts from EvaluatePharma, Roche is set to lead all Big Pharmas in 2026 sales with nearly $62B in expected drug sales that year. […]
FierceBiotech has compiled a list of the top 10 highest paid biopharma R&D executives in 2019. Although one might think that the companies with the biggest […]
By Jim Rudman, CEO, Ashton Tweed and Robert Dickey IV, Managing Director, Foresite Advisors, LLC See this article on LinkedIn. The coronavirus pandemic is just one […]
Sanofi has been under investigation for four years over birth defects tied to epilepsy medicine Depakine, and now the investigation is moving forward on manslaughter charges. […]
DEVELOPING A NOVEL SOLUTION FOR A GROWING PROBLEM A drug crisis has been quietly growing that many people may not be aware of—the abuse of stimulant […]